Your browser doesn't support javascript.
loading
Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure.
van den Berg, Pieter F; Aboumsallem, Joseph Pierre; Screever, Elles M; Shi, Canxia; de Wit, Sanne; Bracun, Valentina; Yousif, Laura I; Geerlings, Lotte; Wang, Dongyu; Ho, Jennifer E; Bakker, Stephan J L; van der Vegt, Bert; Silljé, Herman H W; de Boer, Rudolf A; Meijers, Wouter C.
Afiliación
  • van den Berg PF; Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Aboumsallem JP; Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Screever EM; Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Shi C; Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • de Wit S; Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Bracun V; Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Yousif LI; Department of Cardiology, Thorax Center, Erasmus Medical center, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Geerlings L; Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Wang D; Cardiovascular Institute and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Ho JE; Cardiovascular Institute and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Bakker SJL; Harvard Medical School, Boston, Massachusetts, USA.
  • van der Vegt B; Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Silljé HHW; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • de Boer RA; Department of Experimental Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Meijers WC; Department of Cardiology, Thorax Center, Erasmus Medical center, University Medical Center Rotterdam, Rotterdam, the Netherlands.
JACC CardioOncol ; 5(4): 445-453, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37614579
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: JACC CardioOncol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: JACC CardioOncol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos